Guest guest Posted September 14, 1998 Report Share Posted September 14, 1998 > >Even though SV-40 was being screened out, scientists >such as > , a professor of pathology at the University >of > Southern California, warned that other monkey viruses >could be > dangerous. But government officials rebuffed 's >attempt to > research those risks back in 1978 and again in 1995 when >he was > denied federal funding and vaccine samples he needed to > investigate the effects of simian cytomegalovirus >(SCMV), an > organism that his studies indicate causes neurological >disorders > in the human brain. The virus has been found in monkeys >used for > polio vaccine production. Similarly, Cecil H. Fox was >also > rebuffed when, as a senior scientist at the National >Institutes > of Health in 1988, he asked to examine archived lots of >polio > vaccine to learn whether they contained simian >immunodeficiency > virus (SIV), which has been screened out of polio >vaccines since > 1987 because of potential human impact. " The resistance >of those > in authority to face the issue of prior vaccine >contamination is > particularly unfortunate, " says , " because >research > establishing a viral cause for neurological disorders or >cancers > can lead to effective antiviral treatments. " > > Beginning in 1992, scientific evidence supporting fears >about > prior contamination began to mount. Studies suggested >that SV-40 > was a catalyst for many types of cancer, not only in >people who > had received polio vaccine containing the virus but in >their > children as well. > > In a series of papers published from 1992 through 1996, >Michele > Carbone, a molecular pathologist at Chicago's Loyola >University > Medical Center, examined the same types of tumors in >humans that > were known to develop in hamsters exposed to SV-40. He > discovered SV-40 genes and proteins in 60% of patients >with > mesothelioma, a particularly deadly form of lung cancer, >and in > 38% of those with bone cancer. His most recent research, > presented at a medical conference in July, connects >SV-40 and > these cancers even more clearly by describing the >mechanism > through which SV-40 turns a cell cancerous. Carbone's >research > shows that SV-40 switches off a protein that protects >cells from > becoming malignant. Not everyone who is infected with >SV-40 gets > cancer for the same reason that not every smoker gets >lung > cancer: A variety of assaults on the immune system >usually > combine to trigger malignancy. But SV-40 could be a >factor that > predisposes some people to develop tumors of the brain, >bone, > and tissue that surrounds the lung. > > Now, in what could be a crucial piece of the puzzle, a >study by > Italian researchers published in October in the U.S. >medical > journal Cancer Research suggests that the reason all >three > cancers are on the rise is that the SV-40, originally >introduced > to humans through polio vaccine, is now being spread >sexually > and from mother to child in the womb. The study found >SV-40 > present in the blood and semen of 25% of healthy study >subjects. > According to one of the study's authors, biology and >genetics > professor Mauro Tognon of Italy's University of >Ferrara's School > of Medicine, this would explain why SV-40 was detected >from 1992 > on in the brain tumors of children who were born after >1965 and > therefore presumably did not receive vaccine containing >SV-40. > Tognon also points to SV-40 as one possible reason for >the 30% > increase in U.S. brain tumors over the past 20 years. > > Strickler, senior clinical investigator at the >National > Institutes of Health's National Cancer Institute, told >MONEY > that the federal government is taking recent reports >about SV-40 > very seriously. " They are plausible, but it's not a done >deal, " > Strickler said. > > The accumulating body of evidence from research around >the world > has heightened the fears many scientists have expressed >for > years about the dangers of using monkey tissue in >vaccine > production, particularly when there are safer >alternatives > available. " There's no question that our polio vaccines >should > be made exclusively with killed viruses grown on human >diploid > tissue, " says Urnovitz, a microbiologist in >Berkeley. > > Connaught uses human diploid cells to produce Poliovax, >the > inactivated polio vaccine it manufactures and markets in >Canada. > The company is licensed to sell Poliovax in the U.S. but >now > markets Ipol here, a vaccine grown on monkey tissue. > " Ipol is > the more widely used vaccine, and it was a company >decision [to > continue selling it here] based on what best meets the >needs of > the U.S. market, " Connaught's Grant told >MONEY. > > The FDA is equally dismissive of the potential dangers. > > Patriarca, deputy director of the division of viral >products at > the FDA, says he sees no need to stop producing polio >vaccines > with monkey tissue. > > Government thinking is best summed up by Neal Halsey, >who is a > member of advisory committees on immunization practices >at both > the CDC and the American Academy of Pediatrics. Halsey >cautioned > MONEY against " raising a hypothetical concern that could > jeopardize vaccine supply. If it were a real concern, >the FDA > wouldn't allow the production of vaccine on monkey >tissue. " That > viewpoint, of course, overlooks the fact that the FDA >allowed > the production of polio vaccine that contained SV-40, >SIV and > SCMV, with human health consequences that are just >beginning to > be understood. > > MOVES THAT MUST BE MADE RIGHT NOW > > Evaluating the safety record of vaccines such as DPT and >polio > is especially important in light of the vaccine >industry's > explosive growth. According to Frost & Sullivan, a >technology > market research firm in Mountain View, Calif., current >worldwide > revenues of nearly $3 billion are expected to more than >double > to $7 billion over the next five years as scores of new >vaccines > come to market. The industry is no longer focused >primarily on > life-threatening diseases, or on children but wants to >introduce > adult vaccines like those in the research pipeline to >fight > herpes and other sexually transmitted diseases. > > What can be done in our interest? Much of the necessary >change > involves reforms in public health policy. In a joint >effort with > doctors and scientists, the government should: > > --Ban dangerous products. To immediately improve the >safety of > existing vaccines, we must use only acellular DPT >vaccines and > inactivated polio vaccines. And we must discontinue use >of > monkey tissue in the production of all vaccines. Cost >should not > be a factor. " To avoid even a small risk of brain damage >or > death, what mother wouldn't pay even $50 more for a >safer > vaccine, " says Victor Harding, a Milwaukee attorney who >has > represented parents of children harmed by vaccines. > > --Expand research. " We want to see scientific proof that >you > know precisely what is happening in the human body when >you give > vaccines to our babies, " says Barbara Loe Fisher, >co-founder and > president of the National Vaccine Information Center. >She and > other experts recommend that the NIH take half of the >$415 > million spent on promoting immunization and new vaccine >research > and allocate it to studies investigating the >cause-and-effect > relationship between existing vaccines and immune and > neurological disorders suspected to result from their >use. An > Institute of Medicine committee appointed to evaluate >vaccine > safety in 1994 noted that its analysis had been hampered >by lack > of such studies. Out of 59 health problems suspected to >be > associated with a variety of vaccines, the committee >found that > no scientific studies had been conducted on 40 of them >(see the > table on page 157 for a list of the key risks). To aid >such > evaluations, experts want the FDA and manufacturers to >provide > samples of current and archived vaccines to independent > researchers. > > --Stop hiding facts. When federal health officials and > pediatricians refrain from warning the public about >risks out of > fear that parents will stop immunizing their children, >they > insult parents' intelligence and endanger the public's >health. > Parents deserve the facts so they can make informed >choices. > Geneticist and former NIH researcher Mark Geier says >that when > he speaks out publicly about vaccine risks or testifies >on > behalf of vaccine-damaged children, he is frequently >criticized > by other physicians. Says Geier: " They agree privately >that what > I say is accurate but warn that if I'm not careful, I'll >scare > people away from taking vaccines. That's certainly not >my > goal--my own kids are vaccinated. But if you operate on >the > premise that you can't tell the public about problems >with > vaccines because you'll scare them away, then >unfortunately, the > problems don't get fixed. " > > [sIDEBAR] > > HOW TO KEEP YOUR CHILDREN SAFE > > To ensure that your child gets the benefits of >immunization > while minimizing the risks, follow these steps: > > --BE ASSERTIVE. Request that your child receive the >inactivated > polio vaccine, which is given as a shot rather than >orally, and > the acellular form of DPT. Tell your doctor what you >want well > before you come in for your appointment so he or she can >get the > vaccines in stock. > > --BE INFORMED. Ask to see government " benefit/risk >information " > on each vaccine before your child is immunized. And >discuss with > your doctor any reason your child might be at particular >risk. > Possible risk factors: a personal or family history of >seizures > or neurological disorders, immune system disorders or >previous > bad reactions to vaccines. Also, if your child has a >cold or > other illness, immunization should be delayed because >the risk > of an adverse reaction is higher when the immune system >is > already under assault from another virus or bacterium. > > --BE CAUTIOUS. Your doctor should explain what symptoms >to watch > for--such as high fever or high-pitched screaming--that >might > indicate a serious reaction. Monitor your child closely >after > vaccination, and call your doctor if you suspect a >problem. " If > your doctor is not concerned and you still are, take the >child > to an emergency room, " advises Barbara Loe Fisher of the > National Vaccine Information Center, a nonprofit >organization in > Vienna, Va. that provides vaccine safety information to > consumers and assists those who have suffered adverse >reactions. > For more safety tips, or to learn your legal rights if >your > child is injured by a vaccine, you can call the >organization > at 800-909-SHOT. --A.R. > > [sIDEBAR] > > MORE VACCINE HEALTH RISKS THAT MUST BE CHECKED OUT > > In addition to the vaccine-related problems disclosed in >the > accompanying article, many other risks have been >discovered > through lab experiments and random cases reported by >victims or > doctors. The government and the medical community, >however, have > failed to follow up these findings with the >comprehensive > studies that could prove a definite causal link between >the > vaccine and the disease. A " controlled clinical trial " >is > considered the gold standard of scientific inquiry, and > " controlled observational studies " rank as the next >best. > According to the Institute of Medicine, a private, >nonprofit > organization for the examination of health policy >matters, > neither method of inquiry has been used to check out any > definitive connection between the medical problems >listed in > this table and the vaccines that preliminary scientific >research > suggests can cause them. > > Vaccine DPT > > Problem > Encephalopathy (inflammation of the brain resulting in >loss of > consciousness that can range from stupor to coma); >demyelinating > diseases of the central nervous system (infections of >linings > around nerve cells that can cause problems such as >muscle > weakness and blurred vision); Guillain-Barre syndrome >(nerve > condition characterized by numbness and weakness of the >limbs); > anaphylaxis (severe and sometimes fatal allergic >reaction) > > [Vaccine] Measles > > [Problem] > Epilepsy; optic neuritis (inflammation of the optic >nerve that > causes blurred vision and can be an early sign of >multiple > sclerosis); transverse myelitis (spinal cord disease); > Guillain-Barre syndrome; death from vaccine strain viral >infection > > [Vaccine] Mumps > > [Problem] > Encephalopathy; aseptic meningitis (inflammation of >membranes > covering the brain, causing fever, headaches, stiffness >in the > neck, drowsiness and sometimes loss of consciousness); > sensorineural deafness; sterility; thrombocytopenia (a >reduction > in the number of platelets in the blood, manifested by a >rash, > nosebleeds, a tendency to bruise easily and prolonged >bleeding > from cuts) > > [Vaccine] Oral polio > > [Problem] > Transverse myelitis; death from vaccine strain viral >infection > > [Vaccine] Hepatitis B > > [Problem] > Guillain-Barre syndrome; demyelinating diseases of the >central > nervous system; arthritis > > [sIDEBAR] > > DECEPTIVE NUMBERS AND DANGEROUS DECISIONS > > Since 1990, doctors have been required by law to report >all > adverse vaccine reactions through a centralized federal >system > overseen by the Food and Drug Administration and the >Centers for > Disease Control. But they frequently fail to do >so--either > because they don't recognize that a subsequent health >problem is > related to a vaccination, or they consider it relatively > harmless. From 1991 through August 1996, 48,743 adverse > reactions were reported. Unfortunately, those figures >represent > only a small portion of the dangers. For example, a 1995 >CDC > study found that reporting rates were less than 1% for >serious > reactions such as loss of consciousness after a DPT >shot. A 1994 > survey of doctors' offices in seven states, conducted by >the > National Vaccine Information Center, found that only 28 >of 159 > offices said they file a report after a patient has an >adverse > reaction to a vaccine. > > Underreporting is an important problem because those >figures are > what the FDA relies on to identify exceptionally >dangerous lots > of vaccine. When doctors don't report harmful effects, >there is > little chance a " hot lot " can be identified early in its >market > life and recalled before more children are hurt. What's >more, > unfortunately, even with timely reporting, the FDA is >reluctant > to act. For example, the lot that killed >Silvermintz > produced exactly 70 adverse reactions, including nine > deaths--yet was never taken off the market. Why? " This >lot did > have a relatively large reporting rate for serious and >fatal > reactions, " Marcel Salive, chief of the FDA's >epidemiology > branch, told MONEY, " but there were other lots of >vaccine of > smaller size that had higher numbers of reports in those > categories, so it was felt no action was needed. " > > What does it take to get action? No horror is enough, > apparently. Salive confirms that no lot has been >recalled > because of adverse effects since the centralized >reporting > system was set in place six years ago. --A.R. > > > > > " was the first of nine kids to die after shots >from the > same batch of DPT vaccine. It stayed on the market a >full year. " > > " Health officials were aware that the oral vaccine they > recommended would cause about 10 cases of polio each >year. But > they considered those human sacrifices to be >acceptable. " > > " Why should there be any polio victims when the injected >vaccine > is just as effective as the oral--and doesn't cause >polio? The > answer is that it all comes down to money. " > > " Fears grow about using monkey tissue to make vaccines. >Studies > suggest that one monkey virus that contaminated polio >vaccines > has been a catalyst for cancer in humans. " > ______________________________________________________ Get Your Private, Free Email at http://www.hotmail.com Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.